As of 2026-11-13, the Relative Valuation of Pliant Therapeutics Inc (PLRX) is (77.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.74 USD, the upside of Pliant Therapeutics Inc based on Relative Valuation is -10619.4%.
The range of the Relative Valuation is (98.16) - (55.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 40.7x - 42.4x | 41.6x |
| Forward P/E multiples | 22.9x - 23.1x | 23.0x |
| Fair Price | (98.16) - (55.71) | (77.84) |
| Upside | -13365.4% - -7629.0% | -10619.4% |
| Date | P/E |
| 2026-11-12 | -0.31 |
| 2026-11-11 | -0.32 |
| 2026-11-10 | -0.33 |
| 2026-11-09 | -0.33 |
| 2026-11-06 | -0.34 |
| 2026-11-05 | -0.34 |
| 2026-11-04 | -0.35 |
| 2026-11-03 | -0.36 |
| 2026-11-02 | -0.35 |
| 2026-10-30 | -0.36 |
| 2026-10-29 | -0.36 |
| 2026-10-28 | -0.37 |
| 2026-10-27 | -0.36 |
| 2026-10-26 | -0.35 |
| 2026-10-23 | -0.36 |
| 2026-10-22 | -0.36 |
| 2026-10-21 | -0.37 |
| 2026-10-20 | -0.38 |
| 2026-10-19 | -0.37 |
| 2026-10-16 | -0.37 |
| 2026-10-15 | -0.40 |
| 2026-10-14 | -0.37 |
| 2026-10-13 | -0.40 |
| 2026-10-12 | -0.41 |
| 2026-10-09 | -0.42 |
| 2026-10-08 | -0.41 |
| 2026-10-07 | -0.41 |
| 2026-10-06 | -0.43 |
| 2026-10-05 | -0.43 |
| 2026-10-02 | -0.43 |
| 2026-10-01 | -0.44 |
| 2026-09-30 | -0.45 |
| 2026-09-29 | -0.45 |
| 2026-09-28 | -0.45 |
| 2026-09-25 | -0.45 |
| 2026-09-24 | -0.47 |
| 2026-09-23 | -0.47 |
| 2026-09-22 | -0.47 |
| 2026-09-21 | -0.46 |
| 2026-09-18 | -0.46 |
| 2026-09-17 | -0.47 |
| 2026-09-16 | -0.44 |
| 2026-09-15 | -0.46 |
| 2026-09-14 | -0.48 |
| 2026-09-11 | -0.49 |
| 2026-09-10 | -0.47 |
| 2026-09-09 | -0.48 |
| 2026-09-08 | -0.47 |
| 2026-09-04 | -0.48 |
| 2026-09-03 | -0.47 |